NordLocker rebuilds its encrypted cloud storage from the ground up SELLAS Life Sciences to Participate in the Cantor Fitzgerald Global Healthcare Conference
NEW YORK, Sept. 18, 2023 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS)…
60 Degrees Pharma Withdraws COVID Phase IIB IND, Will Resubmit Pending Assessment of Ability to Meet FDA Requirements
Prompted by advice from FDA regarding study design, 60P Australia Pty Ltd, a majority-owned subsidiary…
60 Degrees Pharma Withdraws COVID Phase IIB IND, Will Resubmit Pending Assessment of Ability to Meet FDA Requirements
Prompted by advice from FDA regarding study design, 60P Australia Pty Ltd, a majority-owned subsidiary…
Theratechnologies to Announce Third Quarter 2023 Financial Results and Provide Business Update
MONTREAL, Sept. 18, 2023 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH)…
Theratechnologies to Announce Third Quarter 2023 Financial Results and Provide Business Update
MONTREAL, Sept. 18, 2023 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH)…
AnaptysBio Announces Appointment of John Orwin as Chairman of the Board of Directors
After more than 15 years serving on AnaptysBio’s Board of Directors, Jamie Topper, M.D., Ph.D.,…
AnaptysBio Announces Appointment of John Orwin as Chairman of the Board of Directors
After more than 15 years serving on AnaptysBio’s Board of Directors, Jamie Topper, M.D., Ph.D.,…
Kinnate Biopharma Inc. Announces Pipeline Updates, Strategic Reprioritization and Workforce Restructuring
Promising exarafenib combination data in NRAS mutant melanoma; intend to select two doses in the…
Kinnate Biopharma Inc. Announces Pipeline Updates, Strategic Reprioritization and Workforce Restructuring
Promising exarafenib combination data in NRAS mutant melanoma; intend to select two doses in the…
Codexis CEO Stephen Dilly Named as Finalist of 2023 Bloom Burton Award
Stephen Dilly Headshot Stephen Dilly, MBBS, PhD, President & CEO of Codexis, Inc. REDWOOD CITY,…
Codexis CEO Stephen Dilly Named as Finalist of 2023 Bloom Burton Award
Stephen Dilly Headshot Stephen Dilly, MBBS, PhD, President & CEO of Codexis, Inc. REDWOOD CITY,…
Relay Therapeutics to Present Clinical Data on RLY-4008 in Advanced FGFR2-Altered Solid Tumors at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
CAMBRIDGE, Mass., Sept. 18, 2023 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a…
Relay Therapeutics to Present Clinical Data on RLY-4008 in Advanced FGFR2-Altered Solid Tumors at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
CAMBRIDGE, Mass., Sept. 18, 2023 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a…
Histogen Announces Board Approval of Complete Liquidation and Dissolution
SAN DIEGO, Sept. 18, 2023 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), today announced that…
Histogen Announces Board Approval of Complete Liquidation and Dissolution
SAN DIEGO, Sept. 18, 2023 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), today announced that…
Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance
WARREN, NJ, Sept. 18, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Timber Pharmaceuticals, Inc. (“Timber”…
Beyond Air® Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder
New data demonstrates a therapeutic effect for at least 10 days after a single subcutaneously…
Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance
WARREN, NJ, Sept. 18, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Timber Pharmaceuticals, Inc. (“Timber”…
Beyond Air® Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder
New data demonstrates a therapeutic effect for at least 10 days after a single subcutaneously…
TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase
MALVERN, Pa., Sept. 18, 2023 (GLOBE NEWSWIRE) — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage…